P-selectin-mediated platelet activation promotes adhesion of non-small cell lung carcinoma cells on vascular endothelial cells under flow

Molecular Medicine Reports

Volumn 5, Issue 4, 2012, Pages 935-942

  Gong, Liang ^a   Mi, Hong Jian ^a   Zhu, Hongchu ^a   Zhou, Xiangdong ^a   Yang, Heping ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Adhesion; Hematogenous metastasis; Lung cancer; P selectin; Platelet activation

Indexed keywords

ALPHA3 INTEGRIN; ALPHA5 INTEGRIN; BETA1 INTEGRIN; INTERCELLULAR ADHESION MOLECULE 1; MESSENGER RNA; PADGEM PROTEIN; VASCULAR CELL ADHESION MOLECULE 1;

ADULT; ARTICLE; CANCER TISSUE; CARCINOMA CELL; CELL ADHESION; CONTROLLED STUDY; ENDOTHELIUM CELL; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; METASTASIS; PROTEIN EXPRESSION; THROMBOCYTE ACTIVATION; VASCULAR ENDOTHELIUM;

ANTIGENS, CD29; BLOOD PLATELETS; CARCINOMA, NON-SMALL-CELL LUNG; CELL ADHESION; CELLS, CULTURED; COCULTURE TECHNIQUES; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; INTEGRIN ALPHA3; INTEGRIN ALPHA5; INTERCELLULAR ADHESION MOLECULE-1; LUNG NEOPLASMS; MEMBRANE GLYCOPROTEINS; P-SELECTIN; PLATELET ACTIVATION; RNA INTERFERENCE; RNA, SMALL INTERFERING; VASCULAR CELL ADHESION MOLECULE-1;

EID: 84863251153     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2012.760     Document Type: Article

References (36)

1. Baldwin DR: Lung cancer: investigation and staging. Medicine 36: 155-161, 2008.
2. Jemal A, Siegel R, Ward E, et al: Cancer statistics, 2008. CA Cancer J Clin 58: 71-96, 2008. (Pubitemid 351521864)
3. Leber MF and Efferth T: Molecular principles of cancer invasion and metastasis (Review). Int J Oncol 34: 881-895, 2009.
4. Borsig L: The role of platelet activation in tumor metastasis. Expert Rev Anticancer Ther 8: 1247-1255, 2008.
5. Tsuruo T and Fujita N: Platelet aggregation in the formation of tumor metastasis. Proc Jpn Acad Ser B Phys Biol Sci 84: 189-198, 2008.
6. Chambers AF, Naumov GN, Varghese HJ, et al: Critical steps in hematogenous metastasis: an overview. Surg Oncol Clin N Am 10: 243-255, 2001. (Pubitemid 32472528)
7. Geiger TR and Peeper DS: Metastasis mechanisms. Biochim Biophys Acta 1796: 293-308, 2009.
8. Joyce JA and Pollard JW: Microenvironmental regulation of metastasis. Nat Rev Cancer 9: 239-252, 2008.
9. Noble S and Pasi J: Epidemiology and pathophysiology of cancer-associated thrombosis. Br J Cancer 13: S2-S9, 2008.
10. Amirkhosravi A, Mousa SA, Amaya M, et al: Inhibition of tumor cell-induced platelet aggregation and lung metastasis by the oral GPIIb/IIIa antagonist XV454. Thromb Haemost 90: 549-554, 2003.
11. Sierko E and Wojtukiewicz MZ: Inhibition of platelet function: does it offer a chance of better cancer progression control? Semin Thromb Hemost 33: 712-721, 2007. (Pubitemid 350157017)
12. Ludwig RJ, Schön MP and Boehncke WH: P-selectin: a common therapeutic target for cardiovascular disorders, inflammation and tumour metastasis. Expert Opin Ther Targets 11: 1103-1117, 2007.
13. Massaguer A, Engel P, Tovar V, et al: Characterization of platelet and soluble-porcine P-selectin (CD62P). Vet Immunol Immunopathol 96: 169-181, 2003. (Pubitemid 37329998)
14. Simanek R, Vormittag R, Ay C, et al: High platelet count associated with venous thromboembolism in cancer patients: results from the Vienna Cancer and Thrombosis Study (CATS). J Thromb Haemost 8: 114-120, 2010.
15. Verheul HM and Pinedo HM: The importance of platelet counts and their contents in cancer. Clin Cancer Res 9: 3219-3221, 2003.
16. Ikeda M, Furukawa H, Imamura H, et al: Poor prognosis associated with thrombocytosis in patients with gastric cancer. Ann Surg Oncol 9: 287-291, 2002. (Pubitemid 34298634)
17. Iwasaki A, Hamanaka W, Harnada T, et al: Significance of platelet counts in patients who underwent surgical treatment for lung metastasis. Int Surg 92: 103-109, 2007.
18. Dymicka-Piekarska V, Matowicka-Karna J, Gryko M, et al: Relationship between soluble P-selectin and inflammatory factors (interleukin-6 and C-reactive protein) in colorectal cancer. Thromb Res 120: 585-590, 2007. (Pubitemid 47094903)
19. Erpenbeck L and Schön MP: Deadly allies: the fatal interplay between platelets and metastasizing cancer cells. Blood 115: 3427-3436, 2010.
20. Jurasz P, Alonso-Escolano D and Radomski MW: Platelet-cancer interactions: mechanisms and pharmacology of tumour cell-induced platelet aggregation. Br J Pharmacol 143: 819-826, 2004.
21. Trikha M, Zhou Z, Timar J, et al: Multiple roles for platelet GPIIb/IIIa and αvβ3 integrins in tumor growth, angiogenesis, and metastasis. Cancer Res 62: 2824-2833, 2002. (Pubitemid 34525767)
22. Fuchs B, Budde U, Schulz A, et al: Flow-based measurements of von Willebrand factor (VWF) function: binding to collagen and platelet adhesion under physiological shear rate. Thromb Res 125: 239-245, 2010.
23. Cominetti MR, Martin AC, Ribeiro JU, et al: Inhibition of platelets and tumor cell adhesion by the disintegrin domain of human ADAM9 to collagen I under dynamic flow conditions. Biochimie 91: 1045-1052, 2009.
24. Borsig L, Wong R and Hynes RO: Synergistic effects of L- and P-selectin in facilitating tumor metastasis can involve non-mucin ligands and implicate leukocytes as enhancers of metastasis. Proc Natl Acad Sci USA 99: 2193-2198, 2002. (Pubitemid 34169037)
25. Baumann K, Kowalczyk D, Gutjahr T, et al: Sulfated and non-sulfated glycopeptide recognition domains of P-selectin glycoprotein ligand 1 and their binding to P- and E-selectin. Angew Chem Int Ed Engl 48: 3174-3178, 2009.
26. Iiizumi M, Mohinta S, Bandyopadhyay S and Watabe K: Tumor-endothelial cell interactions: therapeutic potential. Microvasc Res 74: 114-120, 2007. (Pubitemid 350051022)
27. Skubitz AP: Adhesion molecules. Cancer Treat Res 107: 305-329, 2002.
28. McCarty OJ, Mousa SA, Bray PF and Konstantopoulos K: Immobilized platelets support human colon carcinoma cell tethering, rolling, and firm adhesion under dynamic flow conditions. Blood 96: 1789-1797, 2000. (Pubitemid 30661063)
29. Ley K: cell adhesion under flow. Microcirculation 16: 1-2, 2009.
30. Arnaout MA, Goodman SL and Xiong JP: Structure and mechanics of integrin-based cell adhesion. Cell Biology 19: 495-507, 2007. (Pubitemid 350019555)
31. Wang HB, Wang JT, Zhang L, et al: P-selectin primes leukocyte integrin activation during inflammation. Nat Immunol 8: 882-892, 2007. (Pubitemid 47099040)
32. Gogali A, Charalabopoulos K and Constantopoulos S: Integrin receptors in primary lung cancer. Exp Oncol 26: 106-110, 2004.
33. Syrigos KN, Katirtzoglou N, Kotteas E and Harrington K: Adhesion molecules in lung cancer: implications in the pathogenesis and management. Curr Pharm Des 14: 2173-2183, 2008.
34. Barthel SR, Gavino JD, Descheny L and Dimitroff CJ: Targeting selectins and selectin ligands in inflammation and cancer. Expert Opin Ther Targets 11: 1473-1491, 2007. (Pubitemid 350200482)
35. Borsig L: Antimetastatic activities of modified heparins: selectin inhibition by heparin attenuates metastasis. Semin Thromb Hemost 33: 540-546, 2007.
36. Marathe DD, Buffone A Jr, Chandrasekaran EV, et al: Fluorinated per-acetylated GalNAc metabolically alters glycan structures on leukocyte PSGL-1 and reduces cell binding to selectins. Blood 115: 1303-1312, 2010.